NewAmsterdam Pharma Co N.V.

NAMSW

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001936258

SEC filings (opens in a new tab)

In the last 90 days, NewAmsterdam Pharma Co N.V. insiders filed 1 open-market purchase and 3 sales; 9 institutions reported holding it in 13F filings for Q2 2026, worth $28.1M in total; no superinvestor holds it.

Other share classesNAMS

Q3 2023 vs. Q2 2023

How the institutions holding NewAmsterdam Pharma Co N.V. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023 All holders in Q2 2023

13F holders of NAMSW: Q2 2023 compared with Q3 2023
Measure	Q2 2023	Q3 2023	Change
Holders	19	19	0
Shares	1.49M	1.55M	+62.6K (+4.2%)
Value	$3.94M	$2.88M	−$1.06M (−26.9%)

New holders (1)

Institutions that held NewAmsterdam Pharma Co N.V. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to NAMSW in Q3 2023
Institution	Shares	Value	% of portfolio
UBS Group AG	38	$72	0.00%

Sold out (1)

Institutions that held NewAmsterdam Pharma Co N.V. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of NAMSW in Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Wolverine Asset Management LLC	12,448	$26.0K